GGrantIndex
← Leaderboards

Jill A Rafael-Fortney

Ohio State University

$9,863,077
Attributed
$12,783,816
Total exposure
6
Grants
5
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.2M · FY200525
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$12,783,816 · 6

By mechanism

R01$10,426,627 · 5
T32$2,357,189 · 1

Top collaborators

Most similar at Ohio State University

Same institution · by research overlap

Others in their field

Top investigators on “Gene Expression

Research focus

Gene ExpressionCardiacMuscleMouse ModelMuscular DystrophiesStriated MusclesPublishingCardiomyopathiesMineralocorticoid ReceptorPathologyMyocardiumPharmaceutical PreparationsDuchenne Muscular DystrophyPathogenesisFda ApprovedDystrophinAgonistHeart FailurePreventAldosteroneInjuryMuscular Dystrophy Mouse ModelDrug CombinationsMuscle Function

Grant awards (35)

Functions of skeletal muscle mineralocorticoid receptor signaling in chronic and acute injury$435,618
R01 · FY2025 · AR · contact PI
Mechanisms of mineralocorticoid receptor antagonism on inflammation in muscular dystrophy$416,142
R01 · FY2025 · NS · contact PI
Training to provide the knowledge, skills, and culture to the next generation of cardiovascular scientists$347,504
T32 · FY2025 · HL · contact PI
Functions of skeletal muscle mineralocorticoid receptor signaling in chronic and acute injury$467,592
R01 · FY2024 · AR · contact PI
Mechanisms of mineralocorticoid receptor antagonism on inflammation in muscular dystrophy$417,626
R01 · FY2024 · NS · contact PI
Training to provide the knowledge, skills, and culture to the next generation of cardiovascular scientists$360,631
T32 · FY2024 · HL · contact PI
Mechanisms of mineralocorticoid receptor antagonism on inflammation in muscular dystrophy$447,235
R01 · FY2023 · NS · contact PI
Training to provide the knowledge, skills, and culture to the next generation of cardiovascular scientists$365,572
T32 · FY2023 · HL · contact PI
Mechanisms of mineralocorticoid receptor antagonism on inflammation in muscular dystrophy$445,535
R01 · FY2022 · NS · contact PI
Functions of skeletal muscle mineralocorticoid receptor signaling in chronic and acute injury$367,064
R01 · FY2022 · AR · contact PI
Training to provide the knowledge, skills, and culture to the next generation of cardiovascular scientists$357,433
T32 · FY2022 · HL · contact PI
Functions of skeletal muscle mineralocorticoid receptor signaling in chronic and acute injury$396,657
R01 · FY2021 · AR · contact PI
Training To Provide the Knowledge, Skills, and Culture To the Next Generation of Cardiovascular Scientists$225,434
T32 · FY2021 · HL · contact PI
Functions of skeletal muscle mineralocorticoid receptor signaling in chronic and acute injury$404,388
R01 · FY2020 · AR · contact PI
Training To Provide the Knowledge, Skills, and Culture To the Next Generation of Cardiovascular Scientists$237,124
T32 · FY2020 · HL · contact PI
Functions of skeletal muscle mineralocorticoid receptor signaling in chronic and acute injury$398,576
R01 · FY2019 · AR · contact PI
Training To Provide the Knowledge, Skills, and Culture To the Next Generation of Cardiovascular Scientists$233,858
T32 · FY2019 · HL · contact PI
Functions of skeletal muscle mineralocorticoid receptor signaling in chronic and acute injury$374,719
R01 · FY2018 · AR · contact PI
Training To Provide the Knowledge, Skills, and Culture To the Next Generation of Cardiovascular Scientists$153,780
T32 · FY2018 · HL · contact PI
Therapeutic Potential for Aldosterone Inhibition in Duchenne Muscular Dystrophy$664,132
R01 · FY2017 · HL
Mechanisms and synergies of therapeutic drug treatments in muscular dystrophy$336,875
R01 · FY2017 · NS · contact PI
Training To Provide the Knowledge, Skills, and Culture To the Next Generation of Cardiovascular Scientists$75,853
T32 · FY2017 · HL · contact PI
Mechanisms and synergies of therapeutic drug treatments in muscular dystrophy$336,875
R01 · FY2016 · NS · contact PI
Therapeutic Potential for Aldosterone Inhibition in Duchenne Muscular Dystrophy$708,654
R01 · FY2015 · HL
Mechanisms and synergies of therapeutic drug treatments in muscular dystrophy$336,875
R01 · FY2015 · NS · contact PI
Therapeutic Potential for Aldosterone Inhibition in Duchenne Muscular Dystrophy$658,719
R01 · FY2014 · HL
Mechanisms and synergies of therapeutic drug treatments in muscular dystrophy$333,326
R01 · FY2014 · NS · contact PI
Therapeutic Potential for Aldosterone Inhibition in Duchenne Muscular Dystrophy$699,466
R01 · FY2013 · HL
Mechanisms and synergies of therapeutic drug treatments in muscular dystrophy$335,416
R01 · FY2013 · NS · contact PI
Dig and CASK at the mammalian neuromuscular junction$180,409
R01 · FY2006 · AR · contact PI
Dig and CASK at the mammalian neuromuscular junction$323,944
R01 · FY2005 · AR
Dig and CASK at the mammalian neuromuscular junction$346,069
R01 · FY2004 · AR
Dig and CASK at the mammalian neuromuscular junction$40,115
R01 · FY2004 · AR
Dig and CASK at the mammalian neuromuscular junction$277,300
R01 · FY2003 · AR
Dig and CASK at the mammalian neuromuscular junction$277,300
R01 · FY2002 · AR